Coronary vasodilator reserve is impaired in patients with hypertrophic cardiomyopathy and left ventricular dysfunction (Q57841494)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9842009%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

Coronary vasodilator reserve is impaired in patients with hypertrophic cardiomyopathy and left ventricular dysfunction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9842009%20AND%20SRC:MED&resulttype=core&format=json

hypertrophic cardiomyopathy

7 December 2019

main subject

1 reference

based on heuristic

inferred from title

ventricular dysfunction

1 reference

based on heuristic

inferred from title

left ventricular dysfunction

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9842009%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Franco Cecchi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9842009%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

R Gistri

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9842009%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

I Olivotto

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9842009%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

G Chiriatti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9842009%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

P Elliott

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9842009%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

W J McKenna

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9842009%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

P G Camici

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9842009%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

language of work or name

English

0 references

publication date

1 December 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9842009%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

published in

American Heart Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9842009%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9842009%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9842009%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

972-981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9842009%20AND%20SRC:MED&resulttype=core&format=json

Hypertrophic cardiomyopathy. Clinical spectrum and treatment.

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Progression to left ventricular dilatation in patients with hypertrophic obstructive cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Pathologic fibrosis and matrix connective tissue in the subaortic myocardium of patients with hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Transmural myocardial infarction in hypertrophic cardiomyopathy: a cause of conversion from left ventricular asymmetry to symmetry and from normal-sized to dilated left ventricular cavity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Significance of positive or negative thallium-201 scintigraphy in hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Decreased coronary vasodilatory capacity in hypertrophic cardiomyopathy determined by split-dose thallium-dipyridamole myocardial scintigraphy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Regional thallium-201 washout and myocardial hypertrophy in hypertrophic cardiomyopathy and its relation to exertional chest pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Natural history of hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Hypertrophie cardiomyopathy: A discussion of nomenclature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Analysis of Probability as an Aid in the Clinical Diagnosis of Coronary-Artery Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Optimal use of literature knowledge to improve the Bayesian diagnosis of coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Uptake of oxygen-15-labeled CO2 compared with carbon-11-labeled CO2 in the lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Changes in coronary sinus pH during dipyridamole stress in patients with hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Hypertrophic cardiomyopathy with extreme increase in left ventricular wall thickness: functional and morphologic features and clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Regional myocardial blood flow and metabolism at rest in mildly symptomatic patients with hypertrophic cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Regional myocardial blood flow and glucose utilization in symptomatic patients with hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Emission computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Total and Regional Coronary Blood Flow Measured by Radioactive Microspheres in Conscious and Anesthetized Dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Experimental Subendocardial Ischemia in Dogs with Normal Coronary Arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Myocardial blood flow distribution during ischemia-induced coronary vasodilation in the unanesthetized dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Regional Myocardial Blood Flow in Awake Dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Opposite transmural gradients of coronary resistance and extravascular pressure in the working dog's heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Thallium perfusion and cardiac enzyme abnormalities in patients with familial hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Guidelines for clinical use of cardiac radionuclide imaging. Report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Radionuclide Imaging)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Effect of verapamil on absolute myocardial blood flow in hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Direct comparison of [13N]ammonia and [15O]water estimates of perfusion with quantification of regional myocardial blood flow by microspheres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

Noninvasive quantification of myocardial blood flow in humans. A direct comparison of the [13N]ammonia and the [15O]water techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970152-8

10.1016/S0002-8703(98)70152-8

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9842009%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference